Abstract

Hyaluronan (HA) is best known as an abundantly present extracellular matrix component found throughout the body of all vertebrates, including humans. Recent evidence, however, has demonstrated benefits of providing HA exogenously as a therapeutic modality for several medical conditions. Here we discuss the effects of providing HA treatment to increase innate host defense of the intestine, elucidate the size specific effects of HA, and discuss the role of various HA receptors as potential mediators of the HA effects in the intestine. This review especially focuses on HA interaction with the epithelium because it is the primary cellular barrier of the intestine and these cells play a critical balancing role between allowing water and nutrient absorption while excluding microbes and harmful dietary metabolites that are constantly in that organ's environment.

Highlights

  • Hyaluronan (HA) is best known as an abundantly present extracellular matrix component found throughout the body of all vertebrates, including humans

  • This review especially focuses on HA interaction with the epithelium because it is the primary cellular barrier of the intestine and these cells play a critical balancing role between allowing water and nutrient absorption while excluding microbes and harmful dietary metabolites that are constantly in that organ’s environment

  • High molecular weight HA and fragments of HA can bind to several HA binding receptors including the CD44 receptor, the receptor for HA-mediated motility (RHAMM), HA receptor for endocytosis (HARE), lymphatic vessel endothelial HA receptor (LYVE1), layilin, and toll-like receptors (TLRs-2 and 4) [2] Some investigators have proposed that the signal transduction activated by HA is dependent on the cell-type dependent available HA receptors, cooperatively and/or clustering of HA receptors [3]

Read more

Summary

The Role of Hyaluronan Treatment in Intestinal Innate Host Defense

Hannover Medical School, Germany Suryasarathi Dasgupta, Takeda, United States. Specialty section: This article was submitted to Molecular Innate Immunity, a section of the journal

Frontiers in Immunology
Oral Topical IP IP IP Oral Oral Oral Oral Oral
CURRENT CLINICAL USES OF HA
INNATE HOST DEFENSE IN THE GASTROINTESTINAL TRACT
EXOGENOUS HYALURONAN TREATMENT AND INTESTINAL INNATE HOST DEFENSE
HA SIZING EFFECTS ON INTESTINAL EPITHELIUM
HA RECEPTORS IN INTESTINAL EPITHELIUM
Findings
CONCLUSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call